Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma - Poll - MDSpire

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma

  • By

  • Wenchong Xin

  • Fei Wang

  • Luo Lu

  • Haoyu Zang

  • Bai He

  • Weiying Gu

  • Yuetao Wang

  • November 24, 2025

  • 0 min

Share

Original Source(s)

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma

  • by Wenchong Xin, Fei Wang, Luo Lu, Haoyu Zang, Bai He, Weiying Gu, Yuetao Wang

  • November 24, 2025

Related Content

Potential targets for boron transport in boron neutron capture therapy

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?